- Home
- ICLR vs HMY Comparison
ICLR vs HMY Comparison
Compare ICLR & HMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICLR | HMY |
|---|---|---|
| Founded | 1990 | 1950 |
| Country | Ireland | South Africa |
| Employees | N/A | 34350 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.8B |
| IPO Year | 2001 | N/A |
Fundamental Metrics
Financial Performance| Metric | ICLR | HMY |
|---|---|---|
| Price | $146.18 | $15.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $178.62 | $16.00 |
| AVG Volume (30 Days) | 1.1M | ★ 4.1M |
| Earning Date | 05-12-2026 | 02-04-2016 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $37.43 |
| Revenue Next Year | N/A | $27.44 |
| P/E Ratio | ★ $12.91 | $15.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $66.57 | $13.03 |
| 52 Week High | $211.00 | $26.04 |
Technical Indicators
Market Signals| Indicator | ICLR | HMY |
|---|---|---|
| Relative Strength Index (RSI) | 63.32 | 45.43 |
| Support Level | $99.11 | $15.11 |
| Resistance Level | $188.03 | $16.20 |
| Average True Range (ATR) | 8.29 | 0.64 |
| MACD | 1.04 | -0.25 |
| Stochastic Oscillator | 77.73 | 35.46 |
Price Performance
Historical ComparisonAbout ICLR ICON plc
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is engaged in gold mining and related activities, including exploration, extraction, and processing. The group's primary product is gold bullion, produced at operations in South Africa and Papua New Guinea. Gold byproducts include uranium and silver. Strategic projects such as the Wafi-Golpu Project in the New Guinea Mobile Belt, the Eva Copper Project in the Mt Isa Inlier, Queensland, Australia, and the MAC Copper acquisition position the company as a gold-copper producer. The company operates across South Africa, Papua New Guinea, and Australia.